# OrbiMed Advisors

OrbiMed Advisors is an Asset Manager based in New York, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 1989
- **Assets under management:** ~$20B (per the firm)
- **Website:** www.orbimed.com
- **LinkedIn:** https://www.linkedin.com/company/orbimed-advisors

## Regulatory record

- **CRD number:** 118608
- **SEC file number:** 801-61046
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/118608

## About

OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies. It invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty. The firm manages approximately $20 billion across public and private company investments worldwide.

## Sectors

- Biopharmaceutical
- Medical Device
- Diagnostics/Tools
- Healthcare IT
- Healthcare Services
- Digital Health

## Offices

- San Francisco, CA
- Shanghai, China
- Herzliya, Israel
- Hong Kong
- London, UK

## Questions

### What geographies does OrbiMed cover?

OrbiMed invests globally with offices in New York, San Francisco, Shanghai, Herzliya, Hong Kong, and London. Its portfolio includes companies headquartered in North America, Asia, and Europe, and it has committed over $2 billion specifically to developing-country healthcare infrastructure.

### What sets OrbiMed's model apart from a pure venture capital firm in healthcare?

OrbiMed combines venture capital with public equity hedge funds and a structured credit/royalty business — all under one healthcare mandate. This allows the firm to provide equity early, non-dilutive debt later, and maintain public-market exposure post-IPO, which is uncommon among dedicated life-sciences VCs.

### How large is OrbiMed's team, and what expertise does it bring?

The firm employs over 150 professionals, including scientists, medical experts, and investment staff. This multidisciplinary team supports due diligence across biopharma, medical devices, diagnostics, healthcare IT, and services globally.

### How active is OrbiMed in company creation versus backing existing start-ups?

OrbiMed has backed over 110 life sciences start-ups and its venture portfolio companies have brought over 80 new therapies to patients. The firm engages in both company creation and investment in established private companies, often taking an active role in building management teams and strategic direction.

## Related profiles

- [Orbia Ventures](https://altss.com/profile/orbia-ventures)
- [Orbit Capital](https://altss.com/profile/orbit-capital)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/orbimed-advisors

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology